15-year remission in refractory FLT3-mutated AML attained by sorafenib.

Ann Hematol

Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.

Published: November 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534974PMC
http://dx.doi.org/10.1007/s00277-024-06012-3DOI Listing

Publication Analysis

Top Keywords

15-year remission
4
remission refractory
4
refractory flt3-mutated
4
flt3-mutated aml
4
aml attained
4
attained sorafenib
4
15-year
1
refractory
1
flt3-mutated
1
aml
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!